Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

Antitumor agents. 256. Conjugation of paclitaxel with other antitumor agents: evaluation of novel conjugates as cytotoxic agents.

Antitumor agents. 256. Conjugation of paclitaxel with other antitumor agents: evaluation of novel conjugates as cytotoxic agents. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • Antitumor agents. 256. Conjugation of paclitaxel with other antitumor agents: evaluation of novel conjugates as cytotoxic agents. Abstract Text:

    kyoko nakagawa-gotoKyoko Nakagawa-Goto,seikou nakamuraSeikou Nakamura,kenneth f bastowKenneth F Bastow,alexander nyarkoAlexander Nyarko,chieh-yu pengChieh-Yu Peng,fang-yu leeFang-Yu Lee,fang-chen leeFang-Chen Lee,kuo-hsiung leeKuo-Hsiung Lee,

    Sixteen different taxoid conjugates were prepared by linking various anticancer compounds, including camptothecin (CPT), epipodophyllotoxin (EP), colchicine (COL), and glycyrrhetinic acid (GA), at the 2'- or 7-position on paclitaxel (TXL, 1) through an ester, imine, amine, or amide bond. Newly synthesized conjugates were evaluated for cytotoxic activity against replication of several human tumor cell lines. Among them, TXL-CPT conjugates, 8-10, were more potent than TXL itself against the human prostate carcinoma cell line PC-3 (ED(50)=14.8, 3.1, 19.4nM compared with 55.5nM), and conjugate 10 was also 8-fold more active than TXL against the LN-CAP prostate cancer cell line. These compounds also possessed anti-angiogenesis ability as well as lower inhibitory effects against a normal cell line (MRC-5). Thus, conjugates 8-10 are possible antitumor drug candidates, particularly for prostate cancer.

    Antitumor agents. 256. Conjugation of paclitaxel with other antitumor agents: evaluation of novel conjugates as cytotoxic agents. Publishing Authors By Initials

    k nakagawa-gotoK Nakagawa-Goto,s nakamuraS Nakamura,kf bastowKF Bastow,a nyarkoA Nyarko,cy pengCY Peng,fy leeFY Lee,fc leeFC Lee,kh leeKH Lee,

    For similar cells: cells, cultured: tumor cells, cultured research abstracts see: cells: cells, cultured: tumor cells, cultured research

    PUBMED ID PMID:

    MEDLINE DATE:

    Antitumor agents. 256. Conjugation of paclitaxel with other antitumor agents: evaluation of novel conjugates as cytotoxic agents. Journal Published:

    PUBLICATION TYPE: Research Support, N.I.H., Extr

    Journal: Bioorganic & medicinal chemistry letters

    VOLUME: 17

    Page Numbers: 2894-8

    Journal Abbreviation:

    ISSN: 0960-894X

    DAY: 27

    MONTH: 02

    YEAR: 2007

    Antitumor agents. 256. Conjugation of paclitaxel with other antitumor agents: evaluation of novel conjugates as cytotoxic agents. Information

    Number of References:

    LANGUAGE: eng

    NlmUniqueID: 9107377

    Antitumor agents. 256. Conjugation of paclitaxel with other antitumor agents: evaluation of novel conjugates as cytotoxic agents. Keywords Mesh Terms:

    KEYWORDS: Tumor Cells, Cultured

    MESH TERMS: pharmacology

    Chemical & Substance for Abstract: Antitumor agents. 256. Conjugation of paclitaxel with other antitumor agents: evaluation of novel conjugates as cytotoxic agents. Information

    Substance Name: Paclitaxel

    Registry Number: 33069-62-4

    Grant and Affiliation Information for Antitumor agents. 256. Conjugation of paclitaxel with other antitumor agents: evaluation of novel conjugates as cytotoxic agents.

    AFFILIATION: Natural Products Research Laboratories, School of Pharmacy, University of North Carolina, Chapel Hill, NC 27599, USA.

    Country: England

    England Research PublicationEngland Research Publication

    AGENCY: United States NCI

    GRANT: CA-17625

    ACRONYM: CA

    MEDLINETA: Bioorg Med Chem Lett

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    Antitumor agents 256 Conjugation of paclitaxel with other antitumor agents: evaluation of novel conjugates as cytotoxic agents Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News